AIBIOS

United States
Glenwood City, Wisconsin, United States
+1 949-812-8023 ★

Company profile

AIBIOS company profile

AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.

Business identity

Contact email
[email protected]
Phone number
+1 949-812-8023
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2018-02-12

Headquarters

Headquarters
Glenwood City, Wisconsin, United States
Postal code
92612
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$7.9M
Last funding
Seed / $4.6M / 2021-04-28
Last equity funding
Seed / $4.6M
Investors
1
Lead investors
1
Founders
1
Articles
1

Founders and investors

Founders

Akio Sato

Lead investors

SBI Investment

Investors

SBI Investment

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.